Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class ASSE: 600276

Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing

· Issued by Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment